R. Ganapati
Volume:
70 - Edition:
1 -
Jan/Feb/Mar -
2002
Single-dose ROM treatment tor multilesion paucibacillary leprosy-further observations
C. R. Revankar;
H. O. Bulchand;
V. V. Pai;
R. Ganapati
Volume:
69 - Edition:
4 -
Oct/Nov/Dec -
2001
Can cost of leprosy case detection in urban areas be further reduced?
R. Ganapati;
C. R. Revankar;
V. V. Pai;
S. Kingsley;
S. N. Prasad
Volume:
69 - Edition:
2 -
Apr/May/Jun -
2001
Relapsing multibacillary leprosy - a new dimension to transmission in urban areas
R. Ganapati;
H. O. Bulchand;
V. V. Pai;
S. Kingsley;
C. R. Revankar
Volume:
69 - Edition:
2 -
Apr/May/Jun -
2001
Victory over leprosy stigma
R. Ganapati
Volume:
67 - Edition:
1 -
Jan/Feb/Mar -
1999
Serum markers of treatment success in leprosy
Sumner MacLean1;
Kai Stietenroth2;
Hilmar Prange3;
V. V. Pai4;
R. Ganapati5
Volume:
67 - Edition:
3 -
Jul/Aug/Sep -
1999
Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up
R. Ganapati;
C. R. Revankar;
V. V. Pai;
S. Kingsley
Volume:
67 - Edition:
3 -
Jul/Aug/Sep -
1999
Single-dose treatment for paucibacillary leprosy; clinical problems and management
V. V. Pai;
H. O. Bulchand;
C. R. Revankar;
R. Ganapati
Volume:
67 - Edition:
3 -
Jul/Aug/Sep -
1999
Single-dose treatment for paucibacillary leprosy; field implications
C. R. Revankar;
V. V. Pai;
M. S. Antony Samy;
R. Ganapati
Volume:
68 - Edition:
3 -
Jul/Aug/Sep -
2000
Single-dose treatment for single lesion leprosy; histopathological observations
Asha Shinde;
Uday Khopkar;
V. V. Pai;
R. Ganapati
Volume:
66 - Edition:
1 -
Jan/Feb/Mar -
1998
Relapse of multibacillary leprosy after rifampin and ofloxacin treatment for 28 days; a case report
R. Ganapati;
V. V. Pai;
C. R. Revankar;
S. Kingsley;
H. O. Bulchand
Volume:
66 - Edition:
3 -
Jul/Aug/Sep -
1998
Dr. Ganapati, et al. reply
R. Ganapati;
V. V. Pai;
C. R. Revankar;
H. O. Bulchand;
S. Kingsley;
Kailas Gandewar
Volume:
65 - Edition:
2 -
Apr/May/Jun -
1997
Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions
R. Ganapati;
V. V. Pai;
H. J. Shroff;
Kailas Gandewar
Volume:
65 - Edition:
4 -
Oct/Nov/Dec -
1997
A multicenter study of recombinant lnterferon-alpha2b in the treatment of multibacillary leprosy
R. Ganapati;
V. V. Pai;
Udai Banerji;
Jaykar Thomas;
B. Saha
Volume:
64 - Edition:
4 -
Oct/Nov/Dec -
1996
Dormancy, drug resistance or dependency; some thoughts to ponder
V.P. Shetty;
N.F. Mistry;
M.W. Uplekar;
N.H. Antia;
V.V. Pai;
R. Ganapati
Volume:
62 - Edition:
4 -
Oct/Nov/Dec -
1994
Epidemiological studies in children of a low-endemic region, a high-endemic region, and dwellers of a leprosy colony: evaluation of anti-ND-BSA antibodies and lepromin response
Damayanti H. Shah1;
Rekha R. Vartak3;
Sharad S. Naik4;
Shubhada R. Dandekar2;
R. Ganapati5
Volume:
60 - Edition:
3 -
Jul/Aug/Sep -
1992
Humoral response to nerve glycolipid antigen in sera of leprosy patients
Rekha V. Sahasrabudhe;
Subhada R. Dandekar;
Damayanti H. Shah;
Subhada S. Pandya;
Sharad S. Naik;
Evelyn Sequeira;
R . Ganapati
Volume:
60 - Edition:
2 -
Apr/May/Jun -
1992
Modulan® grip-aids for leprosy patients
Shantaram Yawalkar1, Atul Shah3;
R. Ganapati4;
Yan Lian-Bin5;
Zhang Guo-Chen6;
Chen Hong7;
Kennett Westmacott8;
Werner Osterwalder2
Volume:
73 - Edition:
3 -
Jul/Aug/Sep -
2005
Has the term "elimination" outlived its utility?
R. Ganapati;
V. V. Pai
Volume:
72 - Edition:
4 -
Oct/Nov/Dec -
2004
Epidemiology of leprosy
R. Ganapati;
Bhushan Kumar;
Sunil Dogra;
Inderjeet Kaur
Volume:
57 - Edition:
1 -
Jan/Feb/Mar -
1989
A pilot study of three potential vaccines for leprosy in bombay
R. Ganapati1;
Chandrakant R. Revankar2;
Diana N. J. Lockwood3;
Rowan C. Wilson4;
Janet E. Price5;
Penelope Ashton6;
Leslie A. Ashton7;
Rowena M. Holmes8;
Chad Bennett9;
John L. Stanford10;
Richard J. W. Rees11
Volume:
71 - Edition:
3 -
Jul/Aug/Sep -
2003
Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy
V. P. Shetty1;
A. V. Wakade2;
S. Ghate3;
V. V. Pai4;
R. Ganapati5;
N. H. Antia6